MENU
OCGN
AS OF
Feb 13 closing price
Price
$1.41
Change
-$0.00 (-0.00%)
Capitalization
464.79M
39 days until earnings call
Intraday BUY SELL Signals
Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Apr 19, 2023
OCGN Sees Impressive 7.12% Profit Thanks to AI Trading Robot

OCGN Sees Impressive 7.12% Profit Thanks to AI Trading Robot

This AI trading robot "Day Trader: Medium Volatility Stocks for Active Trading (TA&FA)", was one of the best in our robot factory, generating a 7.12% gain for OCGN over the course of the previous week.

As per the technical analysis, the Stochastic Oscillator for OCGN moved out of oversold territory on April 13, 2023, which could indicate a shift from a downward trend to an upward trend. This may be considered a bullish signal for traders who may want to buy the stock or buy call options.

Tickeron's A.I.dvisor analyzed 79 instances where the Stochastic Oscillator left the oversold zone and found that in 73 of those cases, the stock price moved higher in the following days. This gives a probability of over 90% for a continued upward trend in the case of OCGN.

However, traders should also consider other factors such as market conditions, company news, and earnings reports before making any investment decisions. It's important to note that short-term gains may not necessarily be sustainable in the long run. Therefore, it's crucial to conduct thorough research and analysis before making any investment decisions.

Day Trader: Medium Volatility Stocks for Active Trading (TA&FA)

Related Ticker: OCGN

OCGN in downward trend: 10-day moving average broke below 50-day moving average on February 10, 2026

The 10-day moving average for OCGN crossed bearishly below the 50-day moving average on February 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for OCGN moved out of overbought territory on January 15, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 17 similar instances where the indicator moved out of overbought territory. In of the 17 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on January 27, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OCGN as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for OCGN turned negative on January 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 57 similar instances when the indicator turned negative. In of the 57 cases the stock turned lower in the days that followed. This puts the odds of success at .

OCGN moved below its 50-day moving average on February 04, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OCGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

OCGN broke above its upper Bollinger Band on January 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for OCGN entered a downward trend on February 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 71 cases where OCGN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OCGN advanced for three days, in of 233 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. OCGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (129.870) is normal, around the industry mean (27.870). P/E Ratio (0.000) is within average values for comparable stocks, (45.821). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.882). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (77.519) is also within normal values, averaging (322.949).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OCGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Nektar Therapeutics (NASDAQ:NKTR), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.21B. The market cap for tickers in the group ranges from 58 to 124.7B. VRTX holds the highest valuation in this group at 124.7B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 2%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 23%. ADIL experienced the highest price growth at 2,184%, while VSBC experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 27%. For the same stocks of the Industry, the average monthly volume growth was 11% and the average quarterly volume growth was 1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 82
Price Growth Rating: 61
SMR Rating: 92
Profit Risk Rating: 95
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
OCGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. OCGN showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company, which engages in the development and commercialization of therapies for eye diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11 Great Valley Parkway
Phone
+1 484 328-4701
Employees
84
Web
https://www.ocugen.com
Interact to see
Advertisement
As of August 09, 2025, the financial landscape continues to showcase the dynamic rivalry between Apple Inc. (AAPL) and Tesla, Inc. (TSLA), two titans representing distinct sectors of the technology and automotive industries.
#artificial_intelligence
As of August 9, 2025, the financial landscape presents an intriguing comparison between Meta Platforms Inc. (META) and NVIDIA Corporation (NVDA), two titans in their respective industries.
#artificial_intelligence
Tickeron’s recent strides in deploy­ing AI Trading Agents built on shorter ML cycles have produced striking returns—+204% annualized on NVDA (15 min), +112% on AVGO (15 min), and +106% on KKR (5 min).
#artificial_intelligence#trading
In the rapidly evolving landscape of financial technology, artificial intelligence has emerged as a transformative force, reshaping how investors approach trading.
In the dynamic world of financial markets, artificial intelligence has emerged as a transformative force, enabling traders to navigate volatility with unprecedented precision. Tickeron, a pioneer in AI-driven trading solutions, has revolutionized this space through its innovative brokerage agents.
Tickeron, a leader in AI-driven trading solutions, today announced exceptional results from its AI Trading Agent specialized in KKR stock.
#artificial_intelligence#trading
Tickeron, a pioneer in AI-driven financial tools, today announced exceptional trading results for its AI Trading Agent focused on NVIDIA Corporation (NVDA).
#artificial_intelligence
Tickeron, a leader in AI-driven financial solutions, announces its AI Trading Agent’s remarkable 49.16% annualized return trading the iShares U.S. Aerospace & Defense ETF (ITA). Leveraging advanced Financial Learning Models (FLMs), the agent delivers exceptional results for investors targeting high-growth sectors like aviation and defense.
#artificial_intelligence
Tickeron’s AI Trend Prediction Engine (TPE) stands at the forefront of this revolution, leveraging advanced Financial Learning Models (FLMs) to deliver precise predictions for stocks, ETFs, and mutual funds
#artificial_intelligence
The financial markets in 2025 continue to demonstrate resilience amid economic uncertainties, with artificial intelligence playing a pivotal role in identifying bullish opportunities.
Tickeron, a leader in AI-driven trading solutions, today announced outstanding results from its AI Trading Double Agent, delivering a remarkable +318% annualized return on trades involving Advanced Micro Devices (AMD) and its inverse ETF (AMDS) using a 15-minute timeframe.
#artificial_intelligence
Tickeron, a leader in AI-driven financial analysis, releases a comparative analysis of Invesco QQQ Trust (QQQ) and Invesco NASDAQ 100 ETF (QQQM). Both ETFs show robust year-to-date (YTD) gains of 11.646% for QQQ and 11.703% for QQQM, highlighting their strength in tracking the NASDAQ-100 Index.
#artificial_intelligence
Tickeron releases a comparative analysis of Apple Inc. (AAPL) and Tesla Inc. (TSLA), highlighting key metrics and AI-driven insights for investors. With AAPL at $230.56 and TSLA at $329.31, both stocks are rated as a Buy based on long- and short-term analyses.
#artificial_intelligence
Tickeron, a leader in AI-driven trading solutions, releases a comparative analysis of SPDR Portfolio S&P 500 ETF (SPLG) and Vanguard S&P 500 ETF (VOO), highlighting a tight race with YTD gains of 9.865% for SPLG and 9.870% for VOO.
Tickeron, a leader in AI-driven financial solutions, announces its AI Trading Agent’s remarkable +198% annualized return on AAPU, a fund targeting 200% of Apple Inc.’s (AAPL) daily performance.
#artificial_intelligence
Tickeron, a leader in AI-driven financial solutions, proudly announces Day Trader, an algorithmic trading robot achieving a remarkable 91% annualized return. Engineered for intraday markets, Day Trader leverages pullback strategies and tactical hedging with QID and SOXS to deliver high returns while mitigating risk.
#artificial_intelligence
Tickeron’s AI-powered trading agent, focusing on TNA, UPRO, and URTY, has achieved a remarkable +62% annualized return. This long-only, 60-minute interval strategy leverages 3x ETFs to capture aggressive upside in U.S. small- and large-cap equities, showcasing the power of Tickeron’s Financial Learning Models (FLMs).
Revolutionizing Trading with AI-Powered Patterns Tickeron, a leader in AI-driven financial technology, announces its Real-Time Patterns (RTP) tool, designed to empower traders by scanning thousands of stocks, ETFs, crypto, and forex in minutes. RTP identifies high-probability trading patterns, delivering actionable insights like breakout prices, target prices, and confidence levels
#artificial_intelligence
Tickeron, a leader in AI-driven financial analytics, announces its AI Trend Prediction Engine (TPE), boasting an impressive 86% success rate in forecasting stock trends. This cutting-edge tool empowers traders with precise bullish, bearish, or sideways predictions for over 7,000 stocks, including GOOGL, GOOG, and META. Try it free for 14 days at tickeron.com.
#patterns#artificial_intelligence
In the dynamic world of financial markets, few rivalries capture investor attention like that between Coca-Cola Consolidated, Inc. (COKE) and The Coca-Cola Company (KO).